Biostar Pharmaceuticals, Inc. reported consolidated earnings results for the year ended December 31, 2015. For the year, the company's sales, net were $27,129,609 compared to $61,416,587 a year ago. Loss from operations was $23,757,564 compared to $1,312,695 a year ago.

Loss before income taxes was $23,792,716 compared to income before income taxes of $1,534,631 a year ago. Loss was $25,112,562 compared to net income of $4,848,212 a year ago. Diluted loss per share was $11.4 compared to earnings per share of $2.3 a year ago.

Net cash provided by operating activities was $5,877,213 compared to $3,310,618 a year ago. Purchase of property, plant and equipment was $59,475 compared to $2,869,204 a year ago.